Min Zhao*, Linlin Jia**, #


*Beijing Changping Hospital of Integrated Traditional Chinese and Western Medicine, Beijing 102208, China - **Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China


Objective: In order to investigate prescription preference for antihypertensive drugs in our department, we extracted previous data for analysis. 

Methods: We extracted prescription data from January to November 2016 for all antihypertensive treatment, a ranking for frequency and combination was analyzed. 

Results: The highest rank is double prescriptions accounted for 58.2%, among which angiotensin-converting enzyme inhibitor(ACEI) or angiotensin II receptor antagonist + calcium channel blocker was dominant, the prescription of triple combination accounts for 26%, angiotensin II receptor antagonist + calcium channel blocker + β receptor antagonist was dominant; quadruple combination accounts for 2.1%. The compound preparation accounts for 12.7%. 

Conclusion: The combined use of hypertension in our hospital is basically consistent with the relevant provisions of the guidelines for The prevention and control of hypertension in China (2010 Edition), but there are still some irrational drug use schemes for the combination of drugs.


Hypertension, antihypertensive drugs, the combined use of drugs.